Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Sanofi's middling future, Amgen's $10B shopping list, and a novel pharma lawsuit
Fierce editors discuss Sanofi's uninspiring forecast, Amgen's return to high-dollar dealmaking and a lawsuit that accuses a drug company of deliberately being bad at making drugs.
About This Episode
Sanofi's middling future, Amgen's $10B shopping list, and a novel pharma lawsuit is an episode from FierceBiotech Radio. Fierce editors discuss Sanofi's uninspiring forecast, Amgen's return to high-dollar dealmaking and a lawsuit that accus...
Podcast
This episode belongs to FierceBiotech Radio.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Nov 12, 2015, 32:02 long, audio available.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
